|
Jul 2
|
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
|
|
Jul 1
|
Tonix Pharmaceuticals announces inclusion in Russell 3000, Russell 2000 indexes
|
|
Jun 30
|
Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
|
|
Jun 16
|
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
|
|
Jun 13
|
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
|
|
May 28
|
TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia…
|
|
May 22
|
Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase
|
|
Apr 29
|
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
|
|
Mar 14
|
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
|
|
Mar 13
|
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
|
|
Mar 12
|
Life Sciences Investor Forum Agenda Announced for March 13th
|
|
Mar 12
|
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
|
|
Mar 11
|
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
|
|
Mar 10
|
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
|
|
Feb 24
|
TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…
|
|
Jan 8
|
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
|
|
Oct 9
|
Tonix Pharma Enhances Drug Development with AI Partnership
|
|
Oct 8
|
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
|
|
Aug 6
|
Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens
|
|
Jul 30
|
Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
|